{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T06:31:04Z","timestamp":1791181864145,"version":"4.1.0"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2008,9,1]],"date-time":"2008-09-01T00:00:00Z","timestamp":1220227200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2008,9]]},"DOI":"10.1016\/j.juro.2008.05.050","type":"journal-article","created":{"date-parts":[[2008,7,18]],"date-time":"2008-07-18T08:52:19Z","timestamp":1216371139000},"page":"1034-1041","source":"Crossref","is-referenced-by-count":44,"title":["Effect of Tolterodine Extended Release With or Without Tamsulosin on Measures of Urgency and Patient Reported Outcomes in Men With Lower Urinary Tract Symptoms"],"prefix":"10.1097","volume":"180","author":[{"given":"Eric S.","family":"Rovner","sequence":"first","affiliation":[{"name":"Department of Urology, Medical University of South Carolina, Charleston, South Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Kreder","sequence":"additional","affiliation":[{"name":"Department of Urology, University of Iowa Hospitals and Clinics, Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David O.","family":"Sussman","sequence":"additional","affiliation":[{"name":"University of Medicine and Dentistry of New Jersey, Stratford, New Jersey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven A.","family":"Kaplan","sequence":"additional","affiliation":[{"name":"Department of Urology, Weill Cornell Medical College, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Carlsson","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Bavendam","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghong","family":"Guan","sequence":"additional","affiliation":[{"name":"Pfizer Inc, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2008.05.050_bib1","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/nau.10052","article-title":"The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society","volume":"21","author":"Abrams","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2008.05.050_bib2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.eururo.2006.09.019","article-title":"Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study","volume":"50","author":"Irwin","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.eururo.2006.02.018","article-title":"A shifted paradigm for the further understanding, evaluation, and treatment of lower urinary tract symptoms in men: focus on the bladder","volume":"49","author":"Chapple","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib4","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1524-4733.2004.74008.x","article-title":"The impact of urinary urgency and frequency on health-related quality of life in overactive bladder: results from a national community survey","volume":"7","author":"Coyne","year":"2004","journal-title":"Value Health"},{"key":"10.1016\/j.juro.2008.05.050_bib5","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1464-410X.2004.05039.x","article-title":"Comparison of doxazosin with or without tolterodine in men with symptomatic bladder outlet obstruction and an overactive bladder","volume":"94","author":"Lee","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2008.05.050_bib6","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1002\/nau.10057","article-title":"Detrusor instability with equivocal obstruction: a predictor of unfavorable symptomatic outcomes after transurethral prostatectomy","volume":"21","author":"Machino","year":"2002","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.juro.2008.05.050_bib7","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.urology.2006.03.006","article-title":"Tolterodine extended release improves overactive bladder symptoms in men with overactive bladder and nocturia","volume":"68","author":"Kaplan","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2008.05.050_bib8","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/01.ju.0000067541.73285.eb","article-title":"Combination treatment with an alpha-blocker plus an anticholinergic for bladder outlet obstruction: a prospective, randomized, controlled study","volume":"169","author":"Athanasopoulos","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib9","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1001\/jama.296.19.2319","article-title":"Tolterodine and tamsulosin for treatment of men with lower urinary tract symptoms and overactive bladder: a randomized controlled trial","volume":"296","author":"Kaplan","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.juro.2008.05.050_bib10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/j.1464-410X.2006.06068.x","article-title":"Efficacy and tolerability of tolterodine extended-release in men with overactive bladder and urgency urinary incontinence","volume":"97","author":"Roehrborn","year":"2006","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2008.05.050_bib11","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/S0022-5347(05)00483-0","article-title":"Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction","volume":"175","author":"Abrams","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib12","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.urology.2006.05.042","article-title":"Development and validation of patient-reported outcomes measures for overactive bladder","volume":"68","author":"Coyne","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2008.05.050_bib13","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.urology.2006.05.044","article-title":"Assessment of treatment outcomes in patients with overactive bladder: importance of objective and subjective measures","volume":"68","author":"Abrams","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.juro.2008.05.050_bib14","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1097\/01.ju.0000173630.94559.fd","volume":"174","author":"Lee","year":"2005","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.urology.2008.06.067","article-title":"Tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder symptoms: effects of prostate size","author":"Roehrborn","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib16","unstructured":"Roehrborn CG, Kaplan SA, Kraus SR, Wang JT, Bavendam T and Guan Z: The effects of serum prostate-specific antigen level on the efficacy of tolterodine extended release with or without tamsulosin in men with lower urinary tract symptoms including overactive bladder. Unpublished data."},{"key":"10.1016\/j.juro.2008.05.050_bib17","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.eururo.2006.01.007","article-title":"The validation of the patient perception of bladder condition (PPBC): a single-item global measure for patients with overactive bladder","volume":"49","author":"Coyne","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2008.05.050_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1464-410X.2005.05345.x","article-title":"Validation of the urgency perception scale","volume":"95","author":"Cardozo","year":"2005","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2008.05.050_bib19","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1023\/A:1016370925601","article-title":"Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: the OAB-q","volume":"11","author":"Coyne","year":"2002","journal-title":"Qual Life Res"},{"key":"10.1016\/j.juro.2008.05.050_bib20","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1111\/j.1524-4733.2005.00069.x","article-title":"The validation of patient-rated global assessments of treatment benefit, satisfaction, and willingness to continue\u2013the BSW","volume":"8","author":"Pleil","year":"2005","journal-title":"Value Health"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S002253470801286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S002253470801286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2008.05.050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T01:24:05Z","timestamp":1651195445000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2008.05.050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,9]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1016\/j.juro.2008.05.050"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2008.05.050","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,9]]}}}